Layton Mills and Margaret Curtis agreed to acquire 52% stake in CannPal Animal Therapeutics Limited from AusCann Group Holdings Ltd (ASX:AC8) for AUD1 on March 10, 2023. AusCann also retains the right to re-acquire the shares in CannPal for nominal consideration AUD1 upon the failure of the SPV to fund and complete the agreed development and commercialisation milestones. The SSA contains a sunset date of March 31, 2023.
CannPal Animal Therapeutics Limited
Equities
CP1
AU000000CP17
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
-1.31% | 104B | |
+4.39% | 97.47B | |
+5.88% | 22.25B | |
-13.57% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-11.52% | 16.36B | |
+8.76% | 14.39B | |
+40.62% | 12.37B |